The decision comes as a major blow to Wyeth, based in Madison, N.J., which hopes to market the drug as the first nonhormonal treatment for menopausal symptoms.
From: www.nytimes.com
F.D.A. Seeks More Information From Wyeth on Menopause Drug
Posted by Ruslan Abuzant at 12:56 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment